143 related articles for article (PubMed ID: 10359123)
21. Trypanosoma cruzi reduces the number of high-affinity IL-2 receptors on activated human lymphocytes by suppressing the expression of the p55 and p70 receptor components.
Kierszenbaum F; Cuna WR; Beltz LA; Sztein MB
J Immunol; 1989 Jul; 143(1):275-9. PubMed ID: 2659667
[TBL] [Abstract][Full Text] [Related]
22. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
23. Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells.
Kierszenbaum F; Cuna WR; Beltz LA; Sztein MB
J Immunol; 1990 May; 144(10):4000-4. PubMed ID: 2185317
[TBL] [Abstract][Full Text] [Related]
24. Trypanosoma cruzi-induced decrease in the level of interferon-gamma receptor expression by resting and activated human blood lymphocytes.
Kierszenbaum F; Mejia Lopez H; Tanner MK; Sztein MB
Parasite Immunol; 1995 Apr; 17(4):207-14. PubMed ID: 7624161
[TBL] [Abstract][Full Text] [Related]
25. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
26. T-lymphocyte subpopulations do not express identical combinations of interleukin-2 receptor chains in the early phase of their activation and proliferation.
Perola O; Ripatti A; Pelkonen J
Scand J Immunol; 2000 Aug; 52(2):123-30. PubMed ID: 10931379
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
[TBL] [Abstract][Full Text] [Related]
28. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
29. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E₂ down-regulates the expression of CD25 on bovine T cells, and this effect is mediated through the EP4 receptor.
Maślanka T; Spodniewska A; Barski D; Jasiecka A; Zuśka-Prot M; Ziółkowski H; Markiewicz W; Jaroszewski JJ
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):192-200. PubMed ID: 25001909
[TBL] [Abstract][Full Text] [Related]
31. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers.
Sun A; Chu CT; Liu BY; Wang JT; Leu JS; Chiang CP
Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):116-22. PubMed ID: 10943944
[TBL] [Abstract][Full Text] [Related]
32. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
34. Antibodies recognizing CD24 LAP epitope on human T cells enhance CD28 and IL-2 T cell proliferation.
Salamone MC; Rosselot C; Salamone GV; Barboza M; Kado M; Fainboim L
J Leukoc Biol; 2001 Feb; 69(2):215-23. PubMed ID: 11272271
[TBL] [Abstract][Full Text] [Related]
35. Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?
Kierszenbaum F; Mejia Lopez H; Sztein MB
Immunology; 1993 Nov; 80(3):445-50. PubMed ID: 8288318
[TBL] [Abstract][Full Text] [Related]
36. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
[TBL] [Abstract][Full Text] [Related]
37. Trypanosoma cruzi downregulates the production of interleukin-2, interferon-gamma, interleukin-4 and interleukin-5 by activated human lymphocytes.
Kierszenbaum F; Lopez HM; Sztein MB
J Parasitol; 1996 Aug; 82(4):652-6. PubMed ID: 8691380
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of IFN-gamma production by CD8 T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi.
Diez H; López MC; Del Carmen Thomas M; Guzmán F; Rosas F; Velazco V; González JM; Puerta C
Parasite Immunol; 2006 Mar; 28(3):101-5. PubMed ID: 16441508
[TBL] [Abstract][Full Text] [Related]
39. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages.
Fernandez-Gomez R; Esteban S; Gomez-Corvera R; Zoulika K; Ouaissi A
J Immunol; 1998 Apr; 160(7):3471-9. PubMed ID: 9531308
[TBL] [Abstract][Full Text] [Related]
40. Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes.
Conlon KC; Ochoa AC; Kopp WC; Ortaldo JR; Urba WJ; Longo DL; Young HA
J Immunol; 1992 Nov; 149(10):3278-89. PubMed ID: 1358968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
